Published in Int J Mol Sci on October 30, 2013
Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci (2014) 1.08
Sestrin2 inhibits uncoupling protein 1 expression through suppressing reactive oxygen species. Proc Natl Acad Sci U S A (2014) 0.95
Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanisms. Sleep Biol Rhythms (2015) 0.84
Oxidative stress in cardiovascular disease. Int J Mol Sci (2014) 0.82
The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes. Int J Endocrinol (2015) 0.81
Effects of aerobic exercise training on peripheral brain-derived neurotrophic factor and eotaxin-1 levels in obese young men. J Phys Ther Sci (2016) 0.80
Role of Superoxide Dismutase 2 Gene Ala16Val Polymorphism and Total Antioxidant Capacity in Diabetes and its Complications. Avicenna J Med Biotechnol (2016) 0.79
The interactive effect of improvement of vitamin D status and VDR FokI variants on oxidative stress in type 2 diabetic subjects: a randomized controlled trial. Eur J Clin Nutr (2014) 0.79
Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives? World J Diabetes (2015) 0.78
Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress. Sci Rep (2016) 0.77
Advanced glycation endproducts induce apoptosis of endothelial progenitor cells by activating receptor RAGE and NADPH oxidase/JNK signaling axis. Am J Transl Res (2016) 0.77
In Vivo Imaging of Retinal Oxidative Stress Using a Reactive Oxygen Species-Activated Fluorescent Probe. Invest Ophthalmol Vis Sci (2015) 0.77
Mitochondrial dysfunction and its impact on diabetic heart. Biochim Biophys Acta (2016) 0.76
Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy. J Tradit Complement Med (2015) 0.76
A Combination of Prebiotic Inulin and Oligofructose Improve Some of Cardiovascular Disease Risk Factors in Women with Type 2 Diabetes: A Randomized Controlled Clinical Trial. Adv Pharm Bull (2015) 0.75
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects. Int J Mol Sci (2016) 0.75
Uncoupling of Vascular Nitric Oxide Synthase Caused by Intermittent Hypoxia. Oxid Med Cell Longev (2016) 0.75
Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk. Dis Markers (2015) 0.75
Therapeutic Effects of Bupleurum Polysaccharides in Streptozotocin Induced Diabetic Mice. PLoS One (2015) 0.75
Lixisenatide improves glycemic outcomes of Japanese patients with type 2 diabetes: a meta-analysis. Diabetol Metab Syndr (2016) 0.75
Hierarchical Bayesian Logistic Regression to forecast metabolic control in type 2 DM patients. AMIA Annu Symp Proc (2017) 0.75
The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases. Oxid Med Cell Longev (2017) 0.75
Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PLoS One (2015) 0.75
Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies. Curr Diabetes Rev (2016) 0.75
High Glucose-Induced Hypomethylation Promotes Binding of Sp-1 to Myo-Inositol Oxygenase: Implication in the Pathobiology of Diabetic Tubulopathy. Am J Pathol (2017) 0.75
The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications. Diseases (2016) 0.75
Citral, A Monoterpene Protect Against High Glucose Induced Oxidative Injury in HepG2 Cell In Vitro-An Experimental Study. J Clin Diagn Res (2017) 0.75
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13
Free radicals in the physiological control of cell function. Physiol Rev (2002) 19.62
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2004) 17.79
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (2000) 12.33
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA (2007) 11.87
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA (2006) 11.78
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature (1997) 10.53
Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature (2006) 10.07
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science (1996) 8.57
Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science (1995) 8.17
ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol (2007) 8.10
Diseases of the mitochondrial DNA. Annu Rev Biochem (1992) 6.29
Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev (2002) 6.05
The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev (2002) 5.92
Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol (2004) 5.34
High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett (1997) 5.21
Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev (2007) 4.91
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med (2008) 4.25
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol (2008) 4.20
Advanced protein glycosylation in diabetes and aging. Annu Rev Med (1995) 4.13
Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A (2006) 4.07
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes (2008) 4.05
Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation (2002) 3.84
Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med (2000) 3.53
Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol (2002) 3.39
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A (2000) 3.36
Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol (2006) 3.19
Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest (1994) 3.16
Myocardial cell death in human diabetes. Circ Res (2000) 3.12
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med (2001) 2.91
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation (1999) 2.90
Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res (2010) 2.87
Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology (2003) 2.76
Reactive oxygen species in tumor progression. Front Biosci (2005) 2.72
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res (2003) 2.69
Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol (2004) 2.61
Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes (2007) 2.59
Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care (2007) 2.56
Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A (1992) 2.48
The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal (2005) 2.46
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest (2003) 2.35
Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol (2007) 2.24
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes (2002) 2.20
Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial. Diabetes (2006) 2.17
Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia (2001) 2.15
Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci U S A (1974) 2.06
Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol (2003) 2.05
Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest (1992) 2.01
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res (1993) 1.98
Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev (2009) 1.97
Serum selenium and diabetes in U.S. adults. Diabetes Care (2007) 1.96
Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A (1999) 1.94
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes (2001) 1.92
Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol (2003) 1.81
Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun (1990) 1.80
Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol (2003) 1.79
Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes (2008) 1.78
Protein glycation: a firm link to endothelial cell dysfunction. Circ Res (2004) 1.76
Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res (2005) 1.73
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem (2005) 1.72
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol (2006) 1.70
Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Res Commun (2003) 1.69
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int (2002) 1.68
Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol (2004) 1.66
Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J (1998) 1.65
Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J (2004) 1.64
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab (2010) 1.60
Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol (2000) 1.59
Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J Clin Nutr (2006) 1.57
Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res (2000) 1.56
Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci (2005) 1.53
Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res (1993) 1.53
Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation (2002) 1.52
The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem (1979) 1.51
Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med (1999) 1.51
Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes (2005) 1.50
Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost (2004) 1.48
Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood) (2007) 1.45
Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J (1996) 1.41
Dietary antioxidants and human cancer. Integr Cancer Ther (2004) 1.38
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol (1997) 1.35
Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol (2006) 1.34
Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol (1988) 1.33
Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids (1976) 1.29
Vascular free radical release. Ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res (1994) 1.29
Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal (2005) 1.28
High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci (2003) 1.28
Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol (2007) 1.27
Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic Biol Med (1999) 1.26
Glucose suppresses superoxide generation in metabolically responsive pancreatic beta cells. J Biol Chem (2005) 1.24
Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim Biophys Acta (2011) 1.23
Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogen-activated protein kinase phosphatases. Endocrinology (2008) 1.21
Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia (2001) 1.21
Oxidative stress and antioxidant treatment in diabetes. Ann N Y Acad Sci (2004) 1.19
Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation (2003) 1.18
Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med (2012) 11.25
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes (2010) 1.74
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. Hypertension (2009) 1.62
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab (2010) 1.60
Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J (2007) 1.59
Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox. Eur Heart J (2012) 1.54
Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans. Am J Cardiol (2002) 1.46
Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes. Cytokine (2006) 1.44
Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud (2010) 1.43
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans. J Hypertens (2011) 1.40
Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans. J Am Coll Cardiol (2002) 1.36
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens (2007) 1.32
Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med (2011) 1.30
Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes Care (2008) 1.28
Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation (2005) 1.18
Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care (2002) 1.17
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J (2011) 1.17
Human obesity and endothelium-dependent responsiveness. Br J Pharmacol (2012) 1.14
Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care (2011) 1.13
Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care (2005) 1.08
Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis (2009) 1.08
Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab (2011) 1.06
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol (2009) 1.05
Decreased plasma adiponectin concentration in major depression. Neurosci Lett (2006) 1.04
Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Metabolism (2007) 1.03
No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care (2010) 1.03
Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration. Curr Vasc Pharmacol (2011) 1.02
Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis (2007) 1.01
Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev (2009) 1.01
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation (2005) 1.00
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry (2006) 0.99
Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome. Diabetes Care (2012) 0.99
Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab (2006) 0.99
Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation. Cardiovasc Diabetol (2009) 0.98
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. Eur Heart J (2009) 0.97
Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract (2011) 0.96
Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation (2004) 0.95
The role of H. pylori infection in diabetes. Curr Diabetes Rev (2005) 0.94
Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients. Heart (2012) 0.92
Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res (2004) 0.92
Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss. Int J Cardiol (2013) 0.92
Cardiovascular and metabolic effects of ghrelin. Curr Diabetes Rev (2010) 0.92
Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus. J Diabetes Res (2013) 0.92
Taurine supplementation and diabetes mellitus. Curr Opin Clin Nutr Metab Care (2006) 0.91
Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study. Diabetes Care (2009) 0.91
Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. Stroke (2011) 0.91
Effect of α-lipoic acid on platelet reactivity in type 1 diabetic patients. Diabetes Care (2012) 0.89
Metabolic and cardiovascular effects of ghrelin. Int J Pept (2010) 0.89
Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study. J Interv Card Electrophysiol (2014) 0.88
Inflammation-related effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function. J Intern Med (2010) 0.86
Group of signs: a new method to evaluate glycemic variability. J Diabetes Sci Technol (2008) 0.86
A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). Diabetes Technol Ther (2003) 0.85
Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients. Hum Genet (2012) 0.85
Sildenafil reduces insulin-resistance in human endothelial cells. PLoS One (2011) 0.85
Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology (2005) 0.85
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B). Med Oncol (2013) 0.84
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes. Atherosclerosis (2009) 0.84
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome. J Clin Endocrinol Metab (2013) 0.84
Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease. Neurodegener Dis (2013) 0.84
High rate of helicobacter pylori re-infection in patients affected by type 1 diabetes. Diabetes Care (2002) 0.83
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis. Diabetes Metab Res Rev (2014) 0.83
Reduced respiratory muscle strength and endurance in type 2 diabetes mellitus. Diabetes Metab Res Rev (2012) 0.82
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy. Atherosclerosis (2012) 0.82
Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus. Diabetes Res Clin Pract (2009) 0.82
The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitus. PLoS One (2013) 0.81
Overweight and metabolic and hormonal parameter disruption are induced in adult male mice by manipulations during lactation period. Pediatr Res (2005) 0.81
Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations. Free Radic Res (2003) 0.81
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome. Diabetes Care (2008) 0.81
Pioglitazone reduces monocyte activation in type 2 diabetes. Acta Diabetol (2008) 0.81
Severe leucopenia associated with Sitagliptin use. Diabetes Res Clin Pract (2010) 0.80
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism. Int J Cardiol (2012) 0.80
Hypouricemia linked to an overproduction of nitric oxide is an early marker of oxidative stress in female subjects with type 1 diabetes. Diabetes Metab Res Rev (2008) 0.80
The diabetic lung--a new target organ? Rev Diabet Stud (2012) 0.79
Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients. Acta Diabetol (2013) 0.79
Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome. Am J Physiol Endocrinol Metab (2012) 0.79
Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications. Eur Cytokine Netw (2006) 0.79
Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up. Int J Low Extrem Wounds (2011) 0.79
Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia. Acta Diabetol (2014) 0.78
Concomitant impairment in endothelial function and neural cardiovascular regulation in offspring of type 2 diabetic subjects. Hypertension (2006) 0.78
Occurrence of hypotension in older participants. Which 24-hour ABPM parameter better correlate with? J Gerontol A Biol Sci Med Sci (2012) 0.78
Effect of ranolazine on arterial endothelial function in patients with type 2 diabetes mellitus. Atherosclerosis (2012) 0.78
Nutrient infusion bypassing duodenum-jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects. Am J Physiol Endocrinol Metab (2013) 0.78
Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy. Arch Med Res (2007) 0.78
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. Mol Cell Endocrinol (2013) 0.78
Association between altered circadian blood pressure profile and cardiac end-organ damage in patients with renovascular hypertension. Cardiology (2003) 0.78
Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients. Aging (Albany NY) (2015) 0.78